DE69705896D1 - Verfahren zur Herstellung amorphen Paroxetin-Hydrochlorids - Google Patents

Verfahren zur Herstellung amorphen Paroxetin-Hydrochlorids

Info

Publication number
DE69705896D1
DE69705896D1 DE69705896T DE69705896T DE69705896D1 DE 69705896 D1 DE69705896 D1 DE 69705896D1 DE 69705896 T DE69705896 T DE 69705896T DE 69705896 T DE69705896 T DE 69705896T DE 69705896 D1 DE69705896 D1 DE 69705896D1
Authority
DE
Germany
Prior art keywords
paroxetine hydrochloride
preparation
amorphous paroxetine
amorphous
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69705896T
Other languages
English (en)
Other versions
DE69705896T2 (de
Inventor
Shu-Zhong Wang
Takashi Okazoe
Yasushi Matsumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Publication of DE69705896D1 publication Critical patent/DE69705896D1/de
Application granted granted Critical
Publication of DE69705896T2 publication Critical patent/DE69705896T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69705896T 1996-05-30 1997-05-30 Verfahren zur Herstellung amorphen Paroxetin-Hydrochlorids Expired - Fee Related DE69705896T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13719296 1996-05-30

Publications (2)

Publication Number Publication Date
DE69705896D1 true DE69705896D1 (de) 2001-09-06
DE69705896T2 DE69705896T2 (de) 2002-04-11

Family

ID=15192956

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69705896T Expired - Fee Related DE69705896T2 (de) 1996-05-30 1997-05-30 Verfahren zur Herstellung amorphen Paroxetin-Hydrochlorids

Country Status (6)

Country Link
US (2) US20010021776A1 (de)
EP (2) EP1090918A1 (de)
AT (1) ATE203749T1 (de)
CA (1) CA2206592A1 (de)
DE (1) DE69705896T2 (de)
ES (1) ES2160871T3 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
CN1249686A (zh) * 1997-01-15 2000-04-05 史密丝克莱恩比彻姆有限公司 帕罗西丁制剂
DK0994872T3 (da) 1997-06-10 2001-05-28 Synthon Bv 4-phenylpiperidin-forbindelser
IL137684A0 (en) * 1998-02-06 2001-10-31 Smithkline Beechmam Plc Salts of paroxetine
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
US6168805B1 (en) 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9814316D0 (en) * 1998-07-02 1998-09-02 Smithkline Beecham Plc Novel compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
EP1102764A1 (de) * 1998-08-08 2001-05-30 Smithkline Beecham Plc Salze von paroxetin
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
IN191492B (de) * 1999-05-25 2003-12-06 Ranbaxy Lab Ltd
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
EP1109806B8 (de) 1999-07-01 2003-10-29 Italfarmaco S.p.A. Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2002022609A1 (fr) * 2000-09-14 2002-03-21 Asahi Glass Company, Limited Procede de production de sel de paroxetine sensiblement exempt de solvant organique
WO2002085360A1 (en) * 2001-04-25 2002-10-31 Pentech Pharmaceuticals, Inc. Optimized procedures for the manufacture of paroxetine salts
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (de) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
EP0542355A1 (de) * 1991-11-15 1993-05-19 Merck Frosst Canada Inc. Amorphe (Chinolin-2-ylmethoxy)Indole als Leukotrien-Antagonisten
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
ATE203749T1 (de) 2001-08-15
EP0810224B1 (de) 2001-08-01
EP0810224A1 (de) 1997-12-03
DE69705896T2 (de) 2002-04-11
EP1090918A1 (de) 2001-04-11
US20010021776A1 (en) 2001-09-13
US20030181725A1 (en) 2003-09-25
ES2160871T3 (es) 2001-11-16
CA2206592A1 (en) 1997-11-30

Similar Documents

Publication Publication Date Title
DE69705896D1 (de) Verfahren zur Herstellung amorphen Paroxetin-Hydrochlorids
DE69837615D1 (de) Verfahren zur herstellung von oxazolidinonen
DE69631298D1 (de) Verfahren zur Herstellung von Paroxetinhydrochloridanhydrat
DE69621297T2 (de) Verfahren zur Herstellung wasserlöslicher organischer Silizium-Verbindungen
NO20016226D0 (no) Fremgangsmåte for fremstilling av substituerte formamider
DE69522393D1 (de) Verfahren zur Herstellung von amorphen Propylenpolymeren
DE69622804T2 (de) Verfahren zur Herstellung optisch aktiver 3-Hydroxy-Furanverbindungen
DE59806082D1 (de) Verfahren zur Herstellung von substituierten 4,4'-Diaminostilben-2,2'-disulfonsäuren
DE709363T1 (de) Verfahren zur Herstellung von Carbonatverbindungen
DE59711748D1 (de) Verfahren zur Herstellung von 3-(1-Hydroxyphenyl-1-alkoximinomethyl)dioxazinen
DE69612349T2 (de) Verfahren zur Herstellung von Epoxyverbindungen
DE69933526D1 (de) Verfahren zur Herstellung von optisch aktiven Oxazolidinonderivate
DE69706757T2 (de) Verfahren zur Herstellung von 3-Amino substituierten Crotonaten
DE69710405T2 (de) Verfahren zur Herstellung von primären Amid-Derivaten
DE69733524D1 (de) Verfahren zur Herstellung von Dihydropyranverbindungen
DE59605105D1 (de) Verfahren zur Herstellung von substituierten Aminocarbonyltriazolinonen
DE19983849T1 (de) Verfahren zur Herstellung von N-Vinyl-2-Pyrrolidon durch Vinylierung
DE60001298T2 (de) Verfahren zur Herstellung von Omeprazol
DE69612592T2 (de) Verfahren zur Herstellung einer Aminoverbindung
DE69833365D1 (de) Verfahren zur herstellung optisch aktiver amine
DE69625562D1 (de) Verfahren zur Herstellung von optisch aktiven Cyclohexanolderivaten
DE69208008D1 (de) Verfahren zur Herstellung von 2-Amino-5,6-Dimethoxy Tetralin
DE69500362T2 (de) Verfahren zur Herstellung 5,6-dihydroxyindol-Derivate ausgehend von Dopa
DE59601809D1 (de) Verfahren zur Herstellung von substituierten Aminotriazolinonen
ATA27593A (de) Verfahren zur herstellung von 3-(2-(dimethylamino)ethyl)-n-methyl-1h-indol-5- ethansulfonamid

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee